Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Dihydropyrimidine dehydrogenase activity in cancer patients
R A Fleming, G A Milano, M H Gaspard, et al.
Antiviral Research
|
May 23, 2001
Cellular metabolism in lymphocytes of a novel thioether-phospholipid-AZT conjugate with anti-HIV-1 activity
G L Kucera, C L Goff, N Iyer, et al.
Bone Marrow Transplantation
|
May 7, 1999
Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal disease
J J Perry, R A Fleming, M V Rocco, et al.
The American Journal of Cardiology
|
October 7, 1997
Direct comparison of arbutamine and dobutamine stress testing with myocardial perfusion imaging and echocardiography in patients with coronary artery disease
A R Shehata, A W Ahlberg, L D Gillam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 1996
Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer
R A Fleming, R L Capizzi, H B Muss, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study
R A Fleming, R L Capizzi, G L Rosner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2007
A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan
R S Midgley, D J Kerr, K T Flaherty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 14, 2016
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors
J C Soria, H K Gan, S P Blagden, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Dihydropyrimidine dehydrogenase activity in cancer patients
R A Fleming, G A Milano, M H Gaspard, et al.
Antiviral Research
|
May 23, 2001
Cellular metabolism in lymphocytes of a novel thioether-phospholipid-AZT conjugate with anti-HIV-1 activity
G L Kucera, C L Goff, N Iyer, et al.
Bone Marrow Transplantation
|
May 7, 1999
Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal disease
J J Perry, R A Fleming, M V Rocco, et al.
The American Journal of Cardiology
|
October 7, 1997
Direct comparison of arbutamine and dobutamine stress testing with myocardial perfusion imaging and echocardiography in patients with coronary artery disease
A R Shehata, A W Ahlberg, L D Gillam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 1996
Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer
R A Fleming, R L Capizzi, H B Muss, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study
R A Fleming, R L Capizzi, G L Rosner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2007
A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan
R S Midgley, D J Kerr, K T Flaherty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 14, 2016
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors
J C Soria, H K Gan, S P Blagden, et al.
Page
of 7